Montelukast 10 Mg Oral Tablet

DRUG4 trials

Sponsors

University of California, San Francisco, South Valley University, University of South Florida, October 6 University

Conditions

Acne VulgarisAcute Myocardial Infarction (AMI)Brain TumorsColorectal CancerEndometrial CancerInfusion ReactionMonoclonal AntibodyOvarian Cancer

Early Phase 1

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

Not yet recruitingNCT06887673

University of South FloridaBrain Tumors, Colorectal Cancer, Endometrial Cancer +2

Start: 2025-03-31End: 2026-03-31Target: 56Updated: 2025-03-20

Phase 2

Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions

CompletedNCT04198623

University of California, San FranciscoInfusion Reaction, Monoclonal Antibody

Start: 2020-03-20End: 2024-07-31Updated: 2025-12-15

Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction

RecruitingNCT07537868

October 6 UniversityAcute Myocardial Infarction (AMI)

Start: 2026-04-20End: 2027-10-01Target: 80Updated: 2026-05-08

Phase 3

Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast

Not yet recruitingNCT06340984

South Valley UniversityAcne Vulgaris

Start: 2024-06-30End: 2025-02-28Target: 60Updated: 2024-04-03

Related Papers

Evaluating the efficacy of montelukast in reducing the incidence and severity of monoclonal antibodies-associated infusion reactions (Phase II Study)

Blood2025-11-03